US Stock MarketDetailed Quotes

Editas Medicine (EDIT)

Watchlist

2.900
-0.030-1.02%

Close May 13 15:59 ET

2.905
+0.005+0.17%

Post 17:38 ET

283.93MMarket Cap-2.54P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine (EDIT) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

51.75%-23.06M

21.42%-165.24M

28.32%-36.39M

41.35%-30.84M

12.00%-50.21M

4.16%-47.8M

-59.09%-210.28M

-128.25%-50.76M

-48.31%-52.59M

-47.41%-57.06M

Net income from continuing operations

67.17%-24.98M

32.49%-160.06M

87.62%-5.62M

59.58%-25.12M

21.26%-53.24M

-22.82%-76.09M

-54.74%-237.09M

-140.52%-45.4M

-38.03%-62.14M

-67.80%-67.61M

Operating gains losses

----

1,371.81%2.19M

-66,450.00%-6.64M

--6.64M

----

--149K

--10K

----

Depreciation and amortization

-74.80%483K

-9.16%5.28M

-41.71%805K

-54.91%721K

29.15%1.83M

36.05%1.92M

-4.21%5.81M

-5.80%1.38M

5.61%1.6M

-7.79%1.42M

Other non cash items

-55.14%1.18M

222.37%5.72M

179.09%6.11M

---4.24M

--1.21M

--2.64M

11.22%1.78M

--2.19M

--0

----

Change In working capital

-110.49%-1.85M

-1,005.19%-31.23M

-174.50%-33.21M

-353.79%-11.01M

-172.07%-4.62M

266.98%17.62M

316.44%3.45M

-49.61%-12.1M

-4.89%4.34M

245.81%6.41M

-Change in receivables

-20.13%12.58M

117.93%1.09M

56.34%-7.05M

-6,491.53%-7.54M

-7,900.00%-78K

58.48%15.76M

-20.57%-6.08M

-107.86%-16.14M

186.76%118K

100.05%1K

-Change in prepaid assets

254.29%248K

-75.84%1.06M

-68.20%887K

-44.68%593K

-122.78%-488K

104.36%70K

2,331.47%4.4M

388.12%2.79M

570.00%1.07M

326.19%2.14M

-Change in payables and accrued expense

-678.33%-9.64M

-272.13%-16.07M

-252.46%-15.47M

-1,617.15%-4.1M

-48.70%1.84M

140.14%1.67M

256.10%9.34M

577.37%10.15M

-105.04%-239K

179.78%3.58M

-Change in other current assets

-90.08%709K

181.03%12.62M

-54.36%1.48M

-65.03%1.43M

161.67%2.57M

434.38%7.15M

-32.28%4.49M

170.66%3.23M

72.19%4.09M

-237.36%-4.17M

-Change in other current liabilities

-11.06%-753K

-5,002.58%-11.89M

8.24%-3.36M

-98.85%-1.39M

-233.07%-6.46M

6.22%-678K

95.85%-233K

-198.42%-3.67M

72.89%-698K

10,012.50%4.85M

-Change in other working capital

21.25%-5M

-113.21%-18.04M

---9.7M

--0

---2M

---6.35M

---8.46M

----

Cash from discontinued investing activities

Operating cash flow

51.75%-23.06M

21.42%-165.24M

28.32%-36.39M

41.35%-30.84M

12.00%-50.21M

4.16%-47.8M

-59.09%-210.28M

-128.25%-50.76M

-48.31%-52.59M

-47.41%-57.06M

Investing cash flow

Cash flow from continuing investing activities

-99.89%64K

-14.48%138.67M

-99.81%58K

-52.88%39.57M

-17.91%42.65M

1,288.35%56.39M

4,445.91%162.15M

-50.74%30.96M

181.68%83.98M

300.20%51.95M

Net PPE purchase and sale

156.14%64K

96.17%-338K

110.74%58K

85.18%-433K

104.32%151K

93.91%-114K

-87.03%-8.83M

58.68%-540K

-1,122.18%-2.92M

-162.12%-3.49M

Net investment purchase and sale

--0

-18.70%139.01M

--0

-53.96%40.01M

-23.35%42.5M

2,065.94%56.5M

17,204.86%170.97M

-50.90%31.5M

184.71%86.9M

287.34%55.45M

Cash from discontinued investing activities

Investing cash flow

-99.89%64K

-14.48%138.67M

-99.81%58K

-52.88%39.57M

-17.91%42.65M

1,288.35%56.39M

4,445.91%162.15M

-50.74%30.96M

181.68%83.98M

300.20%51.95M

Financing cash flow

Cash flow from continuing financing activities

-27.77%40.47M

-68.79%17.33M

17.17M

2,201.86%7.41M

-848.44%-1.44M

-52.54%56.03M

10,700.19%55.51M

-99.73%322K

Net common stock issuance

--0

--42.85M

--17.08M

--17.15M

--7.18M

--1.44M

--0

Proceeds from stock option exercised by employees

----

-36.91%494K

-8.92%245K

--21K

-29.19%228K

--0

-18.44%783K

-47.67%269K

--0

-27.80%322K

Net other financing activities

----

-105.20%-2.87M

--0

---2.87M

--55.24M

----

Cash from discontinued financing activities

Financing cash flow

--0

-27.77%40.47M

-68.79%17.33M

--17.17M

2,201.86%7.41M

-848.44%-1.44M

-52.54%56.03M

10,700.19%55.51M

--0

-99.73%322K

Net cash flow

Beginning cash position

10.26%149.32M

6.19%135.42M

68.81%168.32M

108.46%142.42M

95.02%142.57M

6.19%135.42M

-12.29%127.53M

15.38%99.71M

-69.60%68.32M

-44.99%73.1M

Current changes in cash

-421.59%-23M

76.16%13.9M

-153.22%-19M

-17.50%25.9M

96.87%-150K

113.14%7.15M

144.15%7.89M

-13.15%35.71M

122.70%31.39M

-105.21%-4.79M

End cash Position

-11.40%126.32M

10.26%149.32M

68.81%168.32M

108.46%142.42M

95.02%142.57M

6.19%135.42M

15.38%99.71M

-69.60%68.32M

Free cash flow

51.68%-23.15M

24.31%-165.85M

28.96%-36.45M

43.66%-31.28M

17.08%-50.21M

7.40%-47.91M

-60.05%-219.11M

-117.87%-51.3M

-55.50%-55.51M

-51.22%-60.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	51.75%-23.06M	21.42%-165.24M	28.32%-36.39M	41.35%-30.84M	12.00%-50.21M	4.16%-47.8M	-59.09%-210.28M	-128.25%-50.76M	-48.31%-52.59M	-47.41%-57.06M
Net income from continuing operations	67.17%-24.98M	32.49%-160.06M	87.62%-5.62M	59.58%-25.12M	21.26%-53.24M	-22.82%-76.09M	-54.74%-237.09M	-140.52%-45.4M	-38.03%-62.14M	-67.80%-67.61M
Operating gains losses	----	1,371.81%2.19M	-66,450.00%-6.64M	--6.64M	----	----	--149K	--10K	----	----
Depreciation and amortization	-74.80%483K	-9.16%5.28M	-41.71%805K	-54.91%721K	29.15%1.83M	36.05%1.92M	-4.21%5.81M	-5.80%1.38M	5.61%1.6M	-7.79%1.42M
Other non cash items	-55.14%1.18M	222.37%5.72M	179.09%6.11M	---4.24M	--1.21M	--2.64M	11.22%1.78M	--2.19M	--0	----
Change In working capital	-110.49%-1.85M	-1,005.19%-31.23M	-174.50%-33.21M	-353.79%-11.01M	-172.07%-4.62M	266.98%17.62M	316.44%3.45M	-49.61%-12.1M	-4.89%4.34M	245.81%6.41M
-Change in receivables	-20.13%12.58M	117.93%1.09M	56.34%-7.05M	-6,491.53%-7.54M	-7,900.00%-78K	58.48%15.76M	-20.57%-6.08M	-107.86%-16.14M	186.76%118K	100.05%1K
-Change in prepaid assets	254.29%248K	-75.84%1.06M	-68.20%887K	-44.68%593K	-122.78%-488K	104.36%70K	2,331.47%4.4M	388.12%2.79M	570.00%1.07M	326.19%2.14M
-Change in payables and accrued expense	-678.33%-9.64M	-272.13%-16.07M	-252.46%-15.47M	-1,617.15%-4.1M	-48.70%1.84M	140.14%1.67M	256.10%9.34M	577.37%10.15M	-105.04%-239K	179.78%3.58M
-Change in other current assets	-90.08%709K	181.03%12.62M	-54.36%1.48M	-65.03%1.43M	161.67%2.57M	434.38%7.15M	-32.28%4.49M	170.66%3.23M	72.19%4.09M	-237.36%-4.17M
-Change in other current liabilities	-11.06%-753K	-5,002.58%-11.89M	8.24%-3.36M	-98.85%-1.39M	-233.07%-6.46M	6.22%-678K	95.85%-233K	-198.42%-3.67M	72.89%-698K	10,012.50%4.85M
-Change in other working capital	21.25%-5M	-113.21%-18.04M	---9.7M	--0	---2M	---6.35M	---8.46M	----	----	----
Cash from discontinued investing activities
Operating cash flow	51.75%-23.06M	21.42%-165.24M	28.32%-36.39M	41.35%-30.84M	12.00%-50.21M	4.16%-47.8M	-59.09%-210.28M	-128.25%-50.76M	-48.31%-52.59M	-47.41%-57.06M
Investing cash flow
Cash flow from continuing investing activities	-99.89%64K	-14.48%138.67M	-99.81%58K	-52.88%39.57M	-17.91%42.65M	1,288.35%56.39M	4,445.91%162.15M	-50.74%30.96M	181.68%83.98M	300.20%51.95M
Net PPE purchase and sale	156.14%64K	96.17%-338K	110.74%58K	85.18%-433K	104.32%151K	93.91%-114K	-87.03%-8.83M	58.68%-540K	-1,122.18%-2.92M	-162.12%-3.49M
Net investment purchase and sale	--0	-18.70%139.01M	--0	-53.96%40.01M	-23.35%42.5M	2,065.94%56.5M	17,204.86%170.97M	-50.90%31.5M	184.71%86.9M	287.34%55.45M
Cash from discontinued investing activities
Investing cash flow	-99.89%64K	-14.48%138.67M	-99.81%58K	-52.88%39.57M	-17.91%42.65M	1,288.35%56.39M	4,445.91%162.15M	-50.74%30.96M	181.68%83.98M	300.20%51.95M
Financing cash flow
Cash flow from continuing financing activities	0	-27.77%40.47M	-68.79%17.33M	17.17M	2,201.86%7.41M	-848.44%-1.44M	-52.54%56.03M	10,700.19%55.51M	0	-99.73%322K
Net common stock issuance	--0	--42.85M	--17.08M	--17.15M	--7.18M	--1.44M	--0	--0	--0	--0
Proceeds from stock option exercised by employees	----	-36.91%494K	-8.92%245K	--21K	-29.19%228K	--0	-18.44%783K	-47.67%269K	--0	-27.80%322K
Net other financing activities	----	-105.20%-2.87M	--0	--0	--0	---2.87M	--55.24M	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	-27.77%40.47M	-68.79%17.33M	--17.17M	2,201.86%7.41M	-848.44%-1.44M	-52.54%56.03M	10,700.19%55.51M	--0	-99.73%322K
Net cash flow
Beginning cash position	10.26%149.32M	6.19%135.42M	68.81%168.32M	108.46%142.42M	95.02%142.57M	6.19%135.42M	-12.29%127.53M	15.38%99.71M	-69.60%68.32M	-44.99%73.1M
Current changes in cash	-421.59%-23M	76.16%13.9M	-153.22%-19M	-17.50%25.9M	96.87%-150K	113.14%7.15M	144.15%7.89M	-13.15%35.71M	122.70%31.39M	-105.21%-4.79M
End cash Position	-11.40%126.32M	10.26%149.32M	10.26%149.32M	68.81%168.32M	108.46%142.42M	95.02%142.57M	6.19%135.42M	6.19%135.42M	15.38%99.71M	-69.60%68.32M
Free cash flow	51.68%-23.15M	24.31%-165.85M	28.96%-36.45M	43.66%-31.28M	17.08%-50.21M	7.40%-47.91M	-60.05%-219.11M	-117.87%-51.3M	-55.50%-55.51M	-51.22%-60.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm